marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-07-2024
Magenta Therapeutics Financial Ratios 2011-2024 | MGTA
Annual Financial Ratios Magenta Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-0.1 | -0.0 | -2.4 | -5.7 | -5.9 | -2.2 | - | - | - | - | - | - | - |
P/S |
- | - | - | - | - | - | - | - | - | - | - | - | - |
EPS |
-8.4 | -32.6 | -1.3 | -1.7 | -2.1 | -3.1 | -19.1 | -65.2 | - | - | - | - | - |
EV (Enterprise Value) |
-118 M | -5.25 M | 58.7 M | 387 M | 410 M | 79.7 M | -47.4 M | -2.24 M | - | - | - | - | - |
EBITDA per Share |
-9.33 | -33.9 | -1.32 | -1.59 | -2.19 | -3.21 | - | - | - | - | - | - | - |
EV/EBITDA |
-0.7 | -4.8 | -4.8 | -1.2 | - | - | - | - | - | - | - | ||
PEG |
- | -0.33 | -0.17 | 0.04 | - | - | - | - | - | - | - | ||
P/B |
0.0 | 0.0 | 1.0 | 3.0 | 3.2 | 0.9 | - | - | - | - | - | - | - |
P/CF |
-0.1 | -0.0 | -2.9 | -6.6 | -7.6 | -2.5 | - | - | - | - | - | - | - |
ROE % |
-25.79 | 64.18 | -41.20 | -52.07 | -54.37 | -39.49 | - | - | - | - | - | - | - |
ROA % |
-24.28 | -34.26 | -37.45 | -46.37 | -47.53 | -36.56 | - | - | - | - | - | - | - |
ROCE % |
-28.53 | 66.95 | -43.26 | -52.40 | -56.29 | -40.82 | - | - | - | - | - | - | - |
Current Ratio |
17.0 | 8.8 | 11.0 | 13.3 | 10.6 | 13.9 | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Magenta Therapeutics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.74 | -0.51 | -0.54 | - | -3.78 | -12.73 | -8.1 | - | -8.9 | -0.29 | -0.39 | - | -0.3 | -0.32 | -0.36 | - | -0.37 | -0.48 | -0.51 | -0.59 | -0.54 | -0.48 | -0.44 | -0.5 | -0.49 | -3.13 | -4.53 | -3.59 | -3.44 | -8.9 | -3.59 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
-0.87 | -0.65 | -0.69 | - | -4.03 | -13.4 | -8.77 | - | -9.43 | -0.31 | -0.4 | - | -0.29 | -0.33 | -0.38 | - | -0.35 | -0.48 | -0.53 | -0.63 | -0.55 | -0.5 | -0.48 | -0.54 | -0.49 | -3.12 | -4.52 | -3.47 | -3.37 | -9.03 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-24.33 | -25.16 | -2.12 | 23.80 | 46.20 | 76.87 | 46.01 | -5.51 | -14.70 | -46.28 | -41.90 | -31.08 | -83.13 | -125.99 | -169.69 | -156.14 | -172.60 | -174.95 | -177.29 | -179.64 | -174.63 | -159.72 | -144.80 | -129.89 | -99.36 | -144.16 | -188.97 | -149.49 | -168.57 | -84.29 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-23.14 | -23.71 | -33.10 | -30.33 | -35.08 | -32.15 | -29.79 | -28.36 | -36.81 | -28.71 | -36.39 | -28.22 | -74.57 | -112.46 | -151.12 | -139.03 | -153.42 | -154.62 | -155.83 | -157.04 | -153.25 | -142.25 | -131.26 | -120.26 | -124.41 | -22.68 | 79.06 | 115.61 | 130.36 | 65.18 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
- | - | - | - | 23.75 | 47.50 | 34.17 | -5.34 | -14.96 | -48.33 | -43.68 | -32.79 | -45.56 | -48.71 | -53.94 | -41.44 | -58.89 | -62.16 | -61.95 | -58.76 | -53.52 | -48.87 | -44.75 | -40.93 | -9.32 | 18.71 | 65.64 | 73.40 | 54.01 | 37.35 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
21.7 | 34.4 | 39.1 | 17.0 | 13.7 | 19.5 | 13.9 | 8.8 | 4.1 | - | 4.5 | 11.0 | 12.5 | 12.6 | 9.3 | 9.1 | 9.1 | 9.1 | 9.1 | 8.0 | 8.0 | 8.0 | 8.0 | 13.5 | 13.5 | 13.5 | 13.5 | 13.2 | 13.2 | 13.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | 11.5 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | 11.5 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | 11.5 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency